Why the study?
Hypertension contributes to mechanisms of atrial fibrillation and their combined relationship increases the risk of cardiovascular disease and mortality.
Does reducing blood pressure variability improve outcomes in patients with hypertension and atrial fibrillation?
Does reducing blood pressure variability improve outcomes in patients with hypertension and atrial fibrillation?
This review highlights the importance of targeting blood pressure variability in patients with concurrent hypertension and atrial fibrillation to reduce cardiovascular risk.
Answers are grounded in this paper and cite their sources.
Supports targeting BP variability in hypertension with AF; leaves open prospective outcome trials.
The article presents a review of the literature on the role of hypertension in the mechanisms of atrial fibrillation, therelationshipbetweenwhichincreases the risk of cardiovascular disease and mortality. The importance of taking into account the increased variability of BP in the development of target organ damage and adverse cardiovascular events is shown. Approaches to the choice of antihypertensive therapy in patients with hypertension and atrial fibrillation have been identified. It has been found that reducing BP variability can be added as one of the most important strategies in the treatment of hypertension and atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Dotsenko et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: